Interestingly, in children with malaria episodes post-booster dose, the IgG2 and IgG3 levels at M21 were higher than non-malaria controls, while IgG, IgG1, and IgG4 levels were lower, although with the available sample size this was not statistically significant for most comparisons. The gene discussed is IGHG3; the disease is malaria.